Neurovalens is a health-technology company developing non-invasive neurostimulation devices for health concerns. Its mission is to help people manage chronic conditions through technology designed to support wellbeing, offering an alternative to drug-based approaches. The company says its products are designed by neurologists and supported by scientific research.

Its Modius range includes Modius Sleep, a physician-prescribed device for insomnia that has received FDA authorization and EU and UK medical-device approval, according to the company. Neurovalens also offers Modius Spero, a device authorized by the FDA to treat symptoms associated with post-traumatic stress disorder. The company highlights access to Modius Spero through the U.S. Department of Veterans Affairs for eligible veterans. Its website describes the devices as non-invasive and drug-free.

Neurovalens provides patient resources to help users get started, answers to frequently asked questions, and replacement stimulation pads for reorder. The company also shares product, research, and company updates through its news coverage and mailing list. Its work focuses on developing technology-based options for people living with persistent health conditions.